Equitech International Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
TMO | Thermo Fisher Scientific | Outperform |
10
|
$599.43 | $591.94 | 0.10% | 1 | $228.57B |
DHR | Danaher | Outperform |
10
|
$252.80 | $260.33 | 2.85% | 4 | $187.00B |
A | Agilent Technologies | Outperform |
10
|
$147.29 | $138.82 | 1.84% | 10 | $43.16B |
MTD | Mettler-Toledo International | Hold |
13
|
$1.30k | $1.12k | -7.55% | 0 | $27.88B |
ILMN | Illumina | Outperform |
16
|
$139.06 | $159.28 | 7.87% | 9 | $22.10B |
WAT | Waters | Hold |
15
|
$353.86 | $323.50 | -7.73% | 2 | $20.95B |
AVTR | Avantor | Outperform |
16
|
$25.27 | $23.25 | 8.43% | 19 | $17.14B |
PKI | PerkinElmer | Outperform |
16
|
$109.24 | $121.84 | 13.40% | 1 | $13.49B |
BRKR | Bruker | Outperform |
16
|
$91.56 | $73.64 | -1.70% | 1 | $12.61B |
BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$344.25 | $536.80 | 26.86% | 1 | $9.76B |
COHR | Coherent | - |
12
|
$33.97 | $258.00 | -100.00% | 0 | $6.61B |
PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$4.40 | $12.67 | 115.91% | 4 | $1.78B |
LAB | Standard BioTools | Buy |
11
|
$2.78 | $4.00 | 43.88% | 1 | $686.85M |
HBIO | Harvard Bioscience | Buy |
14
|
$4.36 | $7.00 | 60.55% | 2 | $191.82M |
ENZ | Enzo Biochem | - |
8
|
$1.36 | $5.50 | -100.00% | 0 | $62.10M |
DYXC | DiaSys | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.03M |
ASPT | Haber | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.02M |
MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
OMRX | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
LFPI | LifePoint | - |
0
|
$0.00 | $5.50 | 0.00% | 0 | $0.00M |